Stephanie A. Scharf Publications: Legal Issues

  • S. Scharf, G. Sax and S. Marmor (eds.),  Product Liability Litigation: Current Law, Strategies and Best Practices, 3rd Edition. Practising Law Institute (PLI), 2023.
  • S. Scharf, G. Sax and S. Marmor (eds.),  Product Liability Litigation: Current Law, Strategies and Best Practices, 2nd Edition. Practising Law Institute (PLI), 2021.
  • S. Scharf, G. Sax, S. Marmor, and M. Churma, “Expert Evidence — Law, Strategies and Best Practices.”  Product Liability Litigation: Current Law Strategies and Best Practices, 2d Edition. Practising Law Institute (PLI), 2021.
  • “Update on the Law: Illinois Imposes Strict Liability for Sexual Harassment by Any Supervisor.” Client Alert, April 2009.
  • “FDA Proposes Revised CBE Rules and Reiterates Preemptive Authority,” FDLI’s UPDATE, Issue 2, March/April 2008.
  • “Punitive Damages in the Supreme Court: How Much is Too Much?” FDLI’s UPDATE, Issue 3, May/June 2007.
  • “Foreign Plaintiffs Battle to Keep Class Claims in U.S. Courts,” Co-Author, FDLI’s UPDATE, Issue 1, January/February 2007.
  • “New Rulings in Drug Cases Highlight Debate Over Preemption,” Law.com, October 2006.
  • “FDA’s Comments Herald New Strength for Preemption Defense in Drug Product Litigation,” Co-Author, FDLI’s UPDATE, Issue 5, September/October 2006.
  • “The Use of Toxicology in Tort Litigation: A Survey of Federal and State Jurisdictions,” Editor, American Bar Association, May 2005.
  • “FDA Issues Final Guidances for Pharmaceutical Risk Assessment and Risk Management,” Jenner & Block Client Alert, March 2005.
  • “A Business Approach to Minimizing Product Liability Litigation,” Minimizing Product Liability Litigation (Aspatore Books), 2005.
  • “Direct-to-Consumer Advertising of Prescription Pharmaceuticals and Medical Devices,” presented at TechLaw Group, Inc. International CLE Session, April 2004.
  • “The Evidentiary Impact of Regulatory Action on Product Litigation in the United States,” Product Liability Advisory Council, March 2004.
  • “The Use of Epidemiology in Tort Litigation: A Survey of Federal and State Jurisdictions,” Editor, American Bar Association, July 2003.
  • “Secondary Evidence Need Not Recreate Language of Missing Insurance Policy, California Supreme Court Rules,” Jenner & Block Insurance Newsletter, 2003.
  • “Marketing Pharmaceutical Products on the Internet: Managing Risks and Limiting Liabilities in the World of E-Commerce,” Products Liability, American Bar Association, Vol. 12, No.2, 2001.
  • “Communications Specialists Help With Damage Control,” U.S. Business Litigation Magazine, February 1997.